BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Vidarabine

A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus.

299+ PubMed studies analyzed · 24 RCTs · Evidence Score: 47.5

Research Domains

Vidarabine has been studied across 12 research domains including 🛡️ Immunity, 🔬 Oncology, 🫘 Kidney, ✨ Skin & Hair, ❤️ Cardiovascular. The primary research focus is 🛡️ Immunity with 13% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Vidarabine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Monocrotaline
3 shared targets
Decitabine
4 shared targets
Fludrocortisone
3 shared targets
Dexrazoxane
2 shared targets
Dideoxyadenosine
2 shared targets
Bromodeoxyuridine
3 shared targets
Fluvastatin
2 shared targets
Methandrostenolone
3 shared targets
KN
3 shared targets
Dibucaine
4 shared targets
Loading evidence profile...

This evidence profile for Vidarabine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.